Willis Hidalgo <fnupetljq@beringer.net> To: <rootdev@pcroot.cern.ch>, <roottalk@pcroot.cern.ch> Subject: TTTP.OB..stock pick of the week! wrpata Date: Wed, 05 May 2004 03:46:47 -0500 MIME-Version: 1.0 X-Virus-Status: Scanned by norton Content-Type: text/plain; charset=us-ascii Content-Transfer-Encoding: plain ootuul+++ HOT Trading Alert TTTP.OB - .16 CENTS +++wtxyqg OTCBB: TTTP.OB 12 to 20 Plus Enters $400,000,000 Market. Introduces VisionKare(TM) an Eye Specific Supplement for Macular Degeneration. CURRENT_PRICE: $0.16 GET IT NOW! TARGET_PRICE IN NEXT 3-5 DAYS: $0.75 - 0.80 TARGET_PRICE IN NEXT 10 DAYS: $0.92 Did you miss out on ACST, UP 400%?, ICMH, 130%? and others, don't miss out on this one TTTP.OB .. 266338fEx7J2663wJ12mwJ) ++ EXCITING NEWS JUST RELEASED FOR TTTP ++ Before we start with the profile of TTTP we would like to mention something very important: THERE IS BIG PR CAMPAIGN STARTING on May 5th ITS EXPECTED THERE WILL BE HUGE DEMAND FOR TTTP.OB SHARES. SO TAKE ADVANTAGE AND GET IN EARLY. THE TARGET PRICES BELOW ARE PRETTY MUCH REALISTIC. +>+>+> Company Profile +>+>+> 12 to 20 Plus, Inc (otcbb:TTTP) Symbol: TTTP.OB Current Price: $0.16 TARGET PRICE IN NEXT 3-5 DAYS: $0.75 - 0.80 TARGET PRICE IN NEXT 10 DAYS: $0.92 How many times have you seen good stocks but you couldn't get your hands on them in the right moment? We are alerting you to a special company with a unique product that is set to be profiled by many newsletters in the next 5-10 days -- this is your chance to get in! ---------------------------------------------- ABOUT THE COMPANY TTTP is an innovative company with a 21st century approach to the health issues of today. Unlike traditional treatment regimens, TTTP’s approach focuses on less harmful and more natural forms of therapies that yield effective results while minimizing chemical dependence or harsh side effects. 12 to 20 Plus’ believes it has a successful prescription for growth—attracting, retaining and successfully treating integrative health-conscious consumers. 12 to 20 Plus has the products to fit the dynamics and trends of a global market. We Expect some strong demand for this stock in the near future!!!!! tidieq---------------------------------------ejxyya NEWS RELEASE...brcpiv SAN LUIS OBISPO, CA,, Apr. 30, 2004 (MARKET WIRE via COMTEX) -- (TTTP) -- According to a recent poll, Americans dread blindness more than any other disability. Recent studies indicate that by the year 2025, the population of people over the age of 65 in the United States will be six times higher than in 1990. The reason -- "baby boomers" are aging and overall life expectancy is increasing. Since many people diagnosed with macular degeneration are over age 55, the number of cases of macular degeneration in the U.S. will increase significantly as baby boomers age. Said Carol Slavin, President "The market is very large, with about 50 million AMD sufferers worldwide (15 million in the U.S.) and five million new cases each year. Less than 2% of all AMD cases are treated successfully, so an urgent need exists for effective new strategies." We would anticipate significant revenues in the millions of dollars as we increase our distribution capabilities and our VisionKare(TM) brand becomes the "benchmark" for the industry. --------------------fhmcem--------------wsxscc *Forward-Looking...Statements-Disclaimer..gudmge Information within this email contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." fegixj iflnpa vmvugw kyssvx detila jlrutd jddhqc yyulap vonyuj gmesxv rcxdhe
This archive was generated by hypermail 2b29 : Sun Jan 02 2005 - 05:50:07 MET